Literature DB >> 25809351

A couple-based complex intervention for Chinese spousal caregivers and their partners with advanced cancer: an intervention study.

Qiuping Li1,2, Yinghua Xu3, Huiya Zhou3, Alice Yuen Loke2.   

Abstract

BACKGROUND: Guided by the Preliminary Live with Love Conceptual Framework (P-LLCF) for Cancer Couple Dyads, a Caring for Couples Coping with Cancer (4Cs) program was developed to support couples coping with cancer as a unit. This study examined the acceptability, feasibility, and the preliminary effect of the 4Cs program.
METHODS: A pre- and post-intervention study design with no control group was conducted among Chinese cancer patients and their spousal caregivers. Among the 135 couples approached, a total of 117 dyads were successfully recruited at baseline, with 92 dyads successfully followed-up at 6 weeks. Outcome measures, including dyadic mediators (self-efficacy), dyadic appraisal (Cancer Related Communication Problem, CRCP), dyadic coping (Dyadic Coping Inventory, DCI), and dyadic outcomes (physical and mental health, negative and positive emotions, and marital satisfaction), were assessed at T0 (pre-intervention) and T1 (post-intervention). Repeated measures analysis of variance was applied in testing the outcomes of the 4Cs program.
RESULTS: The recruitment and retention rates were 86.7% and 78.6%, respectively. Significant improvements were seen in the couples' scores on overall (total) self-efficacy (P < 0.01), CRCP (P < 0.05), DCI (P < 0.05), the physical component summary (PCS) of SF-12 (P < 0.05), anxiety (P < 0.01), and benefit findings (P < 0.05) from T0 to T1. Spousal caregivers scored significantly higher on self-efficacy (P < 0.05), the PCS (P < 0.01), and anxiety (P < 0.05) than the patients. The overall effect sizes calculated in this study ranged from medium to small.
CONCLUSIONS: This study provides evidence suggesting that the 4Cs program is acceptable, feasible, and improved outcomes in supporting Chinese couples coping with cancer as dyads.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25809351     DOI: 10.1002/pon.3809

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  6 in total

1.  Longitudinal associations between chronic condition discordance and perceived control among older couples.

Authors:  Courtney A Polenick; Kira S Birditt; Angela Turkelson; Sadie M Shattuck; Helen C Kales
Journal:  Psychol Aging       Date:  2022-03-28

2.  The development and evaluation of a web-based complex intervention: The caring for couples coping with colorectal cancer "4Cs: CRC" program.

Authors:  Meizhen Chen; Jiali Gong; Qian Cao; Qiuping Li
Journal:  Asia Pac J Oncol Nurs       Date:  2022-03-09

Review 3.  Self-efficacy in caregivers of adults diagnosed with cancer: An integrative review.

Authors:  Megan C Thomas Hebdon; Lorinda A Coombs; Pamela Reed; Tracy E Crane; Terry A Badger
Journal:  Eur J Oncol Nurs       Date:  2021-03-10       Impact factor: 2.588

4.  A feasibility study of an integrated couples-based supportive programme for Chinese couples living with colorectal cancer.

Authors:  Xingjuan Luo; Jieyu Li; Qian Cao; Liya Sun; Ying Chen; Jie Zhao; Qiuping Li
Journal:  Nurs Open       Date:  2020-11-26

5.  Dyadic coping and its association with emotional functioning in couples confronted with advanced cancer: Results of the multicenter observational eQuiPe study.

Authors:  Janneke van Roij; Natasja Raijmakers; Jeroen Kloover; Evelien Kuip; Tineke Smilde; Lilly-Ann van der Velden; Gary Rodin; Lonneke van de Poll-Franse
Journal:  Psychooncology       Date:  2022-05-23       Impact factor: 3.955

6.  A pilot, quasi-experimental, mixed methods investigation into the efficacy of a group psychotherapy intervention for caregivers of outpatients with cancer: the COPE study protocol.

Authors:  Rathi Mahendran; Joyce Yi Siang Tan; Konstadina Griva; Haikel Asyraf Lim; Hui Ying Ng; Joanne Chua; Siew Eng Lim; Ee Heok Kua
Journal:  BMJ Open       Date:  2015-11-19       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.